Therapeutic significance of ARID1A mutation in bladder cancer

Bladder cancer (BC) develops from the tissues of the urinary bladder and is responsible for nearly 200,000 deaths annually. This review aims to integrate knowledge of recently discovered functions of the chromatin remodelling tumour suppressor protein ARID1A in bladder urothelial carcinoma with a fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Conde, Marina, Frew, Ian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234250/
https://www.ncbi.nlm.nih.gov/pubmed/35750014
http://dx.doi.org/10.1016/j.neo.2022.100814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234250/
https://www.ncbi.nlm.nih.gov/pubmed/35750014
http://dx.doi.org/10.1016/j.neo.2022.100814

Ejemplares similares